Phase III Clinical Study on Favipiravir in Patients with Severe Fever with Thrombocytopenia Syndrome
Phase 3
Completed
- Conditions
- Severe Fever with Thrombocytopenia Syndrome (SFTS)
- Registration Number
- JPRN-jRCT2080223816
- Lead Sponsor
- FUJIFILM Toyama Chemical Co., Ltd. (Former Toyama Chemical Co., Ltd.)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
1.Age:20 years old to less than 85 years old
2.Sex: No restriction
3.Outpatient/hospitalization: Hospitalization
4.Patients who are strongly suspected of SFTS
Exclusion Criteria
1.Patients who have shown a trend toward improvement of symptoms.
2.Patients who are using ribavirin or has used ribavirin for this episode of infection
3.Others
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method safety<br>efficacy<br>Efficacy and Safety
- Secondary Outcome Measures
Name Time Method pharmacokinetics<br>pharmacokinetics